Dietary Salt Restriction in Heart Failure: Where Is the Evidence?

Progress in Cardiovascular Diseases

Volumn 58, Issue 4, 2016, Pages 401-406

  DiNicolantonio, James J ^a   Chatterjee, Subhankar ^b   O'Keefe, James H ^a  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b R G KAR MEDICAL COLLEGE   (India)

Author keywords

Chloride; Heart failure; Hypertension; Salt; Sodium

Indexed keywords

ALDOSTERONE; ANGIOTENSIN I; ANGIOTENSIN II; ARGIPRESSIN; BRADYKININ; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; NORADRENALIN; RENIN; TUMOR NECROSIS FACTOR ALPHA; SALT INTAKE;

APOPTOSIS; CONGESTIVE CARDIOMYOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; DOWN REGULATION; ENZYME ACTIVATION; FIBRINOLYSIS; HEART FAILURE; HEART INDEX; HEART INFARCTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART STROKE VOLUME; HORMONE RELEASE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; HYPONATREMIA; LUNG CONGESTION; MEAN ARTERIAL PRESSURE; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SERUM OSMOLALITY; SODIUM RESTRICTION; SODIUM URINE LEVEL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; WATER ABSORPTION; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; CARDIOLOGY; CLINICAL TRIAL (TOPIC); DIET THERAPY; EUROPE; EVIDENCE BASED MEDICINE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PROCEDURES; PROGNOSIS; SALT INTAKE; UNITED STATES;

AMERICAN HEART ASSOCIATION; CARDIOLOGY; CLINICAL TRIALS AS TOPIC; DIET, SODIUM-RESTRICTED; EUROPE; EVIDENCE-BASED MEDICINE; GUIDELINES AS TOPIC; HEART FAILURE; HUMANS; HYPERTENSION; PROGNOSIS; SOCIETIES, MEDICAL; SODIUM CHLORIDE, DIETARY; UNITED STATES;

EID: 84959308345     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2015.12.002     Document Type: Review

References (56)

1. Heidenreich P.A., Albert N.M., Allen L.A., et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 2013, 6:606-619.
2. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article. Circulation 2005, 112:1825-1852.
3. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008, 10:933-989.
4. National Institute for Health and Clinical Excellence Royal College of Physicians. Chronic heart failure: national clinical guidelines for the diagnosis and management in primary and secondary care [Accessed on February 18, 2015]. http://www.ncgc.ac.uk/Guidelines/Published/21.
5. Heart Failure Society, India About heart failure [Updated 2007], [Accessed on February 18, 2015]. http://www.hfsindia.org/articles.htm.
6. Malcom J., Arnold O., Howlett J.G., et al. Canadian Cardiovascular Society Consensus Conference Guidelines on heart failure-2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol 2008, 24:21-40.
7. Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guidelines for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013, 62:e147-e239.
8. Bernstein A.M., Willett W.C. Trends in 24-h urinary sodium excretion in the United States, 1957-2003: a systematic review. Am J Clin Nutr 2010, 92:1172-1180.
9. Cody R.J., Atlas S.A., Laragh J.H., et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest 1986, 78:1362-1374.
10. Liang F., O'Rear J., Schellenberger U., et al. Evidence for functional heterogeneity of circulating b-type natriuretic peptide. J Am Coll Cardiol 2007, 49:1071-1078.
11. Schrier R.W., Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med 1999, 341:577-585.
12. Chatterjee K. Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol 2005, 95(9A):8B-13B.
13. Heart Failure Society of America HFSA 2006 comprehensive heart failure practice guidelines. J Card Fail 2006, 12:10-38.
14. Intersalt Cooperative Research Group Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988, 297:319-328.
15. Stolarz-Skrzypek K., Kuznetsova T., Thijs L., et al. Fatal and nonfatal outcomes, incidence of hypertension and blood pressure changes in relation to urinary sodium excretion in White Europeans. JAMA 2011, 305:1777-1785.
16. Heer M., Baisch F., Kropp J., Gerzer R., Drummer C. High dietary sodium chloride consumption may not induce body fluid retention in humans. Am J Physiol Renal Physiol 2000, 278:F585-F595.
17. Damgaard M., Norsk P., Gustafsson F., et al. Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1294-R1301.
18. Lennie T.A., Faan R.N., Song E.K., et al. Three gram sodium intake is associated with longer event free survival only in patients with advanced heart failure. J Cardiac Fail 2011, 17:325-330.
19. Graudal N.A., Galloe A.M., Garred P. Effects of sodium restriction on blood pressure, renin, aldosteron, catecholamines, cholesterols and triglyceride. JAMA 1998, 279:1383-1391.
20. Adler A.J., Taylor F., Martin N., et al. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev 2014, 12:CD009217.
21. O'Donnel M., Mente A., Rangarajan S., et al. Urinary sodium and potassium excretion, mortality and cardiovascular events. N Engl J Med 2014, 371:612-623.
22. McCarron D.A., Geerling J.C., Kazaks A.G., Stern J.S. Can dietary sodium intake be modified by public policy. Clin J Am Soc Nephrol 2009, 4:1878-1882.
23. Huynh B.C., Rovner A., Rich M.W. Long-term survival in elderly patients hospitalized for heart failure-14-year follow-up from a prospective randomized controlled trial. Arch Intern Med 2006, 166:1892-1898.
24. Kovesdy C.P., Lott E.H., Lu J.L., et al. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation 2012, 125(5):677-684. [Epub 2012 Jan 5]. 10.1161/CIRCULATIONAHA.111.065391.
25. Alderman M.H. Dietary sodium and cardiovascular disease: the 'J'-shaped relation. J Hypertens 2007, 25:903-907.
26. Graudal N., Jurgens G., Baslund B., Alderman M.H. Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. Am J Hypertens 2014, 27:1129-1137.
27. Nakasato M., Strunk C.M., Guimarães G., et al. Is the low-sodium diet actually indicated for all patients with stable heart failure?. Arq Bras Cardiol 2010, 94:92-101.
28. Folkow B., Ely D. The salt problem revisited-importance of the blood pressure-heart rate relationship. Blood Press 1998, 7:133-138.
29. Tikellis C., Pickering R.J., Tsorotes D., et al. Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with type 1 diabetes. Clin Sci (Lond) 2013, 124:617-626.
30. Tikellis C., Pickering R.J., Tsorotes D., et al. Activation of the renin-angiotensin system mediates the effects of dietary salt intake on atherogenesis in the apolipoprotein E knockout mouse. Hypertension 2012, 60:98-105.
31. Hilgenfeldt U., Puschner T., Riester U., et al. Low-salt diet downregulates plasma but not tissue kallikrein-kinin system. Am J Physiol 1998, 275:F88-F93.
32. Dinicolantonio J.J., Lavie C.J., O'Keefe J.H. Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril. Postgrad Med 2013, 125(4):154-168. 10.3810/pgm.2013.07.2687.
33. Björkqvist J., Jämsä A., Renné T. Plasma kallikrein: the bradykinin-producing enzyme. Thromb Haemost 2013, 110(3):399-407. [Epub 2013 Jul 11]. 10.1160/TH13-03-0258.
34. Klein L., O'Connor C.M., Leimberger J.D., et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the OPTIME-CHF study. Circulation 2005, 111:2454-2460.
35. Gheorghiade M., Rossi J.S., Cotts W., et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med 2007, 167:1998-2005.
36. Movig K.L., Leufkens H.G., Lenderink A.W., et al. Validity of hospital discharge International Classification of Diseases (ICD) codes for identifying patients with hyponatremia. J Clin Epidemiol 2003, 56:530-535.
37. Sica D.A. Hyponatremia and heart failure-pathophysiology and implications. Congest Heart Fail 2005, 11:274-277.
38. Goldsmith S.R., Francis G.S., Cowley A.W. Arginine vasopressin and the renal response to water loading in congestive heart failure. Am J Cardiol 1986, 58:295-299.
39. Greenberg A. Diuretic complications. Am J Med Sci 2000, 319:10-24.
40. Binanay C., Califf R.M., Hasselblad V., et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005, 294:1625-1633.
41. Krumholz H.M., Chen Y.T., Bradford W.D., Cerese J. Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction. Am J Manag Care 1999, 5:715-723.
42. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 333:1190-5.
43. Rossi J., Bayram M., Udelson J.E., et al. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial. Acute Card Care 2007, 9:82-86.
44. Deubner N., Berliner D., Frey A., Güder G., Brenner S., Fenske W., Allolio B. ErtlG, Angermann CE, Störk S. Dysnatraemia in heart failure. Eur J Heart Fail 2012 Oct, 14(10):1147-1154. PubMed PMID:22820314Epub 2012 Jul 20.
45. Gasowski J., Cwynar M. There is more to salt than just a pinch of sodium. Hypertension 2013, 62:829-830.
46. De Bacquer D., De Backer G., De Buyzere M., Kornitzer M. Is low serum chloride level a risk factor for cardiovascular mortality?. J Cardiovasc Risk 1998, 5:177-184.
47. McCallum L., Jeemon P., Hastie C.E., et al. Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension 2013, 62:836-843.
48. Yang H., Huang L.Y., Zeng D.Y., et al. Decrease of intracellular chloride concentration promotes endothelial cel inflammation by activating nuclear factor-κB pathway. Hypertension 2012, 60:1287-1293.
49. Hiraoka M., Kawano S., Hirano Y., Furukawa T. Role of cardiac chloride currents in changes in action potential characteristics and arrhythmias. Cardiovasc Res 1998, 40:23-33.
50. Berend K., van Hulsteijn L.H., Gans R.O. Chloride: the queen of electrolytes?. Eur J Intern Med 2012, 23:203-211.
51. Licata G., Di Pasquale P., Parrinello G., et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J 2003, 145:459e66.
52. Paterna S., Di Pasquale P., Parrinello G., et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure. J Am Coll Cardiol 2005, 45:1997e2003.
53. Paterna S., Parrinello G., Cannizzaro S., et al. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol 2009, 103:93e102.
54. Parrinello G., et al. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restrictionin patients with compensated heart failure with New York Heart Association Class III (Class C) (SMAC-HF study). Am J Med Sci 2011, 342:27e37.
55. Paterna S., Gaspare P., Fasullo S., et al. Normal-sodium diet compared with low sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?. Clin Sci (Lond) 2008, 114:221e30.
56. Van Horn L. Dietary sodium and blood pressure: how low should we go?. Prog Cardiovasc Dis 2015, 58(1):61-68. [Epub 2015 May 21]. 10.1016/j.pcad.2015.05.008.